CClinicalTrials.gg
CompletedNCT01454518Updated Mar 11, 2013

Local Infiltration Analgesia for Hip Arthroscopy

An interventional study of Infiltration of local anesthetic and Normal Saline Injection in Pain, sponsored by Trinity Health Of New England. Completed at 1 site in United States. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2013-03-11.

Sponsored by Trinity Health Of New England · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

The purpose of this study is to examine if ultrasound guided infiltration of local anesthetic solution around the hip joint will provide effective pain control after hip arthroscopy.

02

Conditions studied

  • Pain

Keywords

  • hip arthroscopy
  • post operative analgesia
03

In context

Lead sponsor

Trinity Health Of New England is the lead sponsor of 19 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • hip arthroscopy
  • ages 18-80

Exclusion criteria

Exclusion Criteria:

  • history of neurological disease
  • diabetes
  • pregnancy
  • neuropathy
  • chronic narcotic use
  • allergy to local anesthetic solution
  • inability to give consent or cooperate with the study protocol
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Care provider)
Enrollment
36 participants (actual)

Study arms

  • Experimental
    Infiltration of local anesthetic

    30 ml of ropivacaine 0.5% infiltrated around lateral anterior and medial aspect of hip joint with ultrasound guidance.

    Procedure: Infiltration of local anesthetic

  • Placebo comparator
    Normal Saline Injection

    injection of 30ml normal saline infiltrated around lateral anterior and medial aspect of hip joint with ultrasound guidance.

    Procedure: Normal Saline Injection

Interventions

  • ProcedureInfiltration of local anesthetic

    30 ml of ropivacaine 0.5% infiltrated around lateral anterior and medial aspect of hip joint with ultrasound guidance.

  • ProcedureNormal Saline Injection

    injection of 30ml normal saline infiltrated around lateral anterior and medial aspect of hip joint with ultrasound guidance.

06

What researchers measure

Primary outcomes

  1. Post operative opioid consumption.

    Amount in milligrams of opioid consumption post surgery in the recovery room and for a 24 hour period.

    Time frame: Within 24 hours after surgery

Secondary outcomes

  1. Pain scores in recovery room.

    Mesures of pain score using numeric pain rating scale (0=no pain, 10=worst pain) completed by patient in recovery room and every 6 hours for a 24 hour period after discharge from recovery room.

    Time frame: Within 24 hours of the surgery

07

Study locations

1 site
  • Saint Francis Hospital and Medical Center
    Hartford, Connecticut 06105, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 11, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01454518
Lead sponsor
Trinity Health Of New England
Responsible party
Sponsor
First posted
Oct 19, 2011
Start date
Oct 2011
Primary completion
Sep 2012
Completion
Feb 2013
Last update
Mar 11, 2013

Study contacts

Sanjay Sinha, M.D.
principal investigator · Saint Francis Hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion